Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results GlobeNewswire December 11, 2025 NEWARK, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the first quarter fiscal year 2026 ended October 31, 2025. “We remain pleased with the progress of our pivotal Phase 3 TransportNPC(TM) study […]
Nusano Receives “Best Companies to Work For” Award from Utah Business State's top workplaces identified by employee survey data GlobeNewswire December 11, 2025 WEST VALLEY CITY, Utah, Dec. 11, 2025 (GLOBE NEWSWIRE) — Nusano, physics company working to transform radioisotope production and enable industries ranging from healthcare to nuclear energy, today received a Best Companies
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE(TM)-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC GlobeNewswire December 11, 2025 TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week 8 Clinically Meaningful Reductions
Preferred Bank Announces Dividend Increase GlobeNewswire December 11, 2025 LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the larger independent commercial banks in California, today reported that the Board of Directors has increased the annual cash dividend to $3.20 per share from the previous $3.00 per share, an increase
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire December 11, 2025 WATERTOWN, Mass., Dec. 11, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results GlobeNewswire December 11, 2025 KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the second quarter fiscal 2026, which ended October 31, 2025. Financial Highlights Generated revenue
Oruka Therapeutics Announces New Board Member and Board Transition Appoints accomplished commercial leader Chris Martin to its Board of Directors GlobeNewswire December 11, 2025 MENLO PARK, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment
NEWTOWN SQUARE, PA, Dec. 11, 2025 (GLOBE NEWSWIRE) — Mullen Hospitality Management (“MHM”) has been appointed as the official franchise operator JW Marriott Costa Elena All-Inclusive in Costa Rica, introducing the JW Marriott brand's first-ever all-inclusive experience. It also marks the first time Mullen Hospitality Management operates a JW Marriott all-inclusive resort. The project includes
(Copenhagen:ZEAL), Company announcement – No. 25 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, December 11, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78),), a biotechnology company transforming the future of metabolic health, has by decision of the
Compass, Inc. (NYSE: COMP), the largest residential real estate brokerage in the United States and a leading tech-enabled real estate services company, releases its first Housing Market Outlook, a forward-looking view of what's ahead for the U.S. market in 2026 and beyond. Developed by Compass Chief Economist Mike Simonsen, the report explains how the market